Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. Februar 2020 03:05 ET | Quelle: WPD Pharmaceuticals

WPD Pharmaceuticals’ Annamycin Received Positive Interim Results From Phase 1/2 Clinical Studies in Acute Myeloid Leukemia

VANCOUVER, British Columbia, Feb. 27, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company is pleased to provide...
24. Februar 2020 03:05 ET | Quelle: WPD Pharmaceuticals

WPD Pharmaceuticals Granted Key Patent Exclusively Licensed From Wake Forest University

VANCOUVER, British Columbia , Feb. 24, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to...
20. Februar 2020 03:05 ET | Quelle: WPD Pharmaceuticals

WPD Pharmaceuticals' STAT3 Inhibitor Received FDA Approval of IND Status in Pediatric Brain Cancer Trial

VANCOUVER, British Columbia, Feb. 20, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company is pleased to provide...
18. Februar 2020 07:35 ET | Quelle: WPD Pharmaceuticals

WPD Pharmaceuticals’ WP1220 Drug Demonstrates Median Reduction of 56% in Skin Cancer Lesions in Clinical Trials

VANCOUVER, British Columbia, Feb. 18, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, in collaboration...
12. Februar 2020 03:05 ET | Quelle: WPD Pharmaceuticals

WPD Pharmaceuticals to Conduct Clinical Trials in Pediatric Brain Tumors Through Collaboration With CNS Pharmaceuticals

VANCOUVER, British Columbia, Feb. 12, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to...
10. Februar 2020 03:05 ET | Quelle: WPD Pharmaceuticals

WPD Pharmaceuticals’ WP1066 Drug Candidate Had Breakthrough Discovery

VANCOUVER, British Columbia, Feb. 10, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to...
05. Februar 2020 03:05 ET | Quelle: WPD Pharmaceuticals

WPD Pharmaceuticals’ Annamycin Drug Received FDA Approval of Fast Track Designation

VANCOUVER, British Columbia, Feb. 05, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO) (FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to...
03. Februar 2020 03:05 ET | Quelle: WPD Pharmaceuticals

WPD Pharmaceuticals Completed the Acquisition of Two Drug Candidates Bringing Total Development Funding Spent on Drugs Under License to Over USD $100 Million

VANCOUVER, British Columbia, Feb. 03, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, provides an update...
31. Januar 2020 16:05 ET | Quelle: WPD Pharmaceuticals

WPD Pharmaceuticals Completed the Acquisition of Two Pancreatic Cancer Drug Candidates

VANCOUVER, British Columbia, Jan. 31, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, provides this update...
29. Januar 2020 03:05 ET | Quelle: WPD Pharmaceuticals

WPD Pharmaceuticals Receives European Patent for Cancer Targeting Drugs

VANCOUVER, British Columbia, Jan. 29, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1)(“WPD” or the “Company”) a clinical stage pharmaceutical company, is pleased to announce...

Vorherige Seite

Nächste Seite